{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:01:44Z","timestamp":1791903704664,"version":"4.3.4"},"reference-count":110,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.biologicals.2004.07.001","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T22:45:53Z","timestamp":1095201953000},"page":"115-128","source":"Crossref","is-referenced-by-count":62,"title":["Assessment of the viral safety of antivenoms fractionated from equine plasma"],"prefix":"10.1016","volume":"32","author":[{"given":"Thierry","family":"Burnouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elwyn","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Seddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Stephano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2004.07.001_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120021113","article-title":"Snake antivenoms","volume":"41","author":"Lalloo","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1081\/CLT-120021115","article-title":"Marine antivenoms","volume":"41","author":"Currie","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/oxfordjournals.bmb.a072619","article-title":"Venomous bites and stings","volume":"49","author":"Warrell","year":"1993","journal-title":"Br Med Bull"},{"key":"10.1016\/j.biologicals.2004.07.001_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0041-0101(03)00098-9","article-title":"A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa","volume":"42","author":"Laing","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0041-0101(97)00160-8","article-title":"Venoms, antivenoms and immunotherapy","volume":"36","author":"Chippaux","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1067\/mem.2001.113372","article-title":"Efficacy, safety, and use of snake antivenoms in the United States","volume":"37","author":"Dart","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.biologicals.2004.07.001_bib8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0041-0101(91)90002-9","article-title":"Antivenoms: a list of hyperimmune sera currently available for the treatment of envenoming by bites and stings","volume":"29","author":"Theakston","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib9","series-title":"Handbook of clinical toxicology of animal venoms and poisons","first-page":"493","article-title":"Clinical toxicology of snakebite in Asia","author":"Warrell","year":"1995"},{"key":"10.1016\/j.biologicals.2004.07.001_bib10","first-page":"515","article-title":"Snake-bites: appraisal of the global situation","volume":"76","author":"Chippaux","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2004.07.001_bib11","series-title":"Handbook of toxicology of animal venoms and poisons","first-page":"645","article-title":"Clinical toxicology of snakebite in Central America","author":"Guti\u00e9rrez","year":"1995"},{"key":"10.1016\/j.biologicals.2004.07.001_bib12","series-title":"Handbook of clinical toxicology of animal venoms and poisons","first-page":"221","article-title":"Clinical toxicology of scorpion stings","author":"Dehesa-D\u00e1vila","year":"1995"},{"key":"10.1016\/j.biologicals.2004.07.001_bib13","first-page":"123","article-title":"Development of an improved method for production of antiscorpion F(ab\u2032)2 fragment of IgG with high yield and potency","volume":"11","author":"Seddik","year":"2002","journal-title":"J Nat Toxins"},{"key":"10.1016\/j.biologicals.2004.07.001_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1081\/CLT-120021114","article-title":"Antivenom treatment in arachnidism","volume":"41","author":"Isbister","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib15","first-page":"51","article-title":"Emergence of transmissible disorders, a continuous process\u2014a new type of viral meningoencephalitis","volume":"104","author":"Ivan","year":"2000","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.biologicals.2004.07.001_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1439-0450.2002.00530.x","article-title":"Recent developments in the epidemiology of virus diseases","volume":"49","author":"Kaaden","year":"2002","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.biologicals.2004.07.001_bib17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(03)14121-9","article-title":"Possible role of an animal vector in the SARS outbreak at Amoy Gardens","volume":"362","author":"Ng","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2004.07.001_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/423003b","article-title":"Biologists seek to head off future sources of infection","volume":"423","author":"Abbott","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2004.07.001_bib19","series-title":"Note for guidance on production and quality control of animal immunoglobulins and immunsera for human use","year":"2002"},{"key":"10.1016\/j.biologicals.2004.07.001_bib20","doi-asserted-by":"crossref","first-page":"39960","DOI":"10.1074\/jbc.M206978200","article-title":"Structure of arterivirus nsp4. The smallest chymotrypsin-like proteinase with an alpha\/beta C-terminal extension and alternate conformations of the oxyanion hole","volume":"277","author":"Barrette-Ng","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2004.07.001_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/viro.2002.1466","article-title":"Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horses","volume":"298","author":"Moore","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2004.07.001_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0166-0934(01)00416-5","article-title":"Detection of equine arteritis virus by real-time TaqMan reverse transcription-PCR assay","volume":"101","author":"Balasuriya","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2004.07.001_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1020109801925","article-title":"Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus","volume":"25","author":"Giese","year":"2002","journal-title":"Virus Genes"},{"key":"10.1016\/j.biologicals.2004.07.001_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1051\/vetres:2002002","article-title":"Borna disease: current knowledge and virus detection in France","volume":"33","author":"Dauphin","year":"2002","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2004.07.001_bib25","doi-asserted-by":"crossref","first-page":"d470","DOI":"10.2741\/ikuta","article-title":"Borna disease virus and infection in humans","volume":"7","author":"Ikuta","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.biologicals.2004.07.001_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.20506\/rst.19.1.1217","article-title":"Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology","volume":"19","author":"Ludwig","year":"2000","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.biologicals.2004.07.001_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1354\/vp.38-4-451","article-title":"Clinical, pathologic, immunohistochemical, and virologic findings of eastern equine encephalomyelitis in two horses","volume":"38","author":"Del Piero","year":"2001","journal-title":"Vet Pathol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/JCM.41.1.379-385.2003","article-title":"Detection of North American eastern and western equine encephalitis viruses by nucleic acid amplification assays","volume":"41","author":"Lambert","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib29","first-page":"621","article-title":"Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis","volume":"165","author":"Jochim","year":"1974","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.biologicals.2004.07.001_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3201\/eid0803.010199","article-title":"Eastern equine encephalomyelitis virus infection in a horse from California","volume":"8","author":"Franklin","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biologicals.2004.07.001_bib31","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1128\/JCM.38.12.4523-4526.2000","article-title":"Characterization of a coronavirus isolated from a diarrheic foal","volume":"38","author":"Guy","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib32","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1128\/JVI.76.14.7220-7227.2002","article-title":"Further characterization of equine foamy virus reveals unusual features among the foamy viruses","volume":"76","author":"Lecellier","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1439-0450.2002.00590.x","article-title":"Detection and isolation of equine herpesviruses 1 and 4 from horses in Normandy: an autopsy study of tissue distribution in relation to vaccination status","volume":"49","author":"Taouji","year":"2002","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.biologicals.2004.07.001_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/01652176.2002.9695126","article-title":"Equine herpesvirus 1 and 4 infections: an update","volume":"24","author":"van Maanen","year":"2002","journal-title":"Vet Q"},{"key":"10.1016\/j.biologicals.2004.07.001_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(01)00299-4","article-title":"Detection of equine herpesvirus type 2 (EHV-2) in horses with keratoconjunctivitis","volume":"80","author":"Kershaw","year":"2001","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2004.07.001_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1051\/vetres:2002013","article-title":"Prevalence of equine herpesvirus types 2 and 5 in horse populations by using type-specific PCR assays","volume":"33","author":"Nordengrahn","year":"2002","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2004.07.001_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0166-0934(02)00101-5","article-title":"Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV)","volume":"105","author":"Cook","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2004.07.001_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/01652176.2002.9695127","article-title":"Equine influenza virus infections: an update","volume":"24","author":"van Maanen","year":"2002","journal-title":"Vet Q"},{"key":"10.1016\/j.biologicals.2004.07.001_bib39","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1128\/JVI.74.21.9972-9979.2000","article-title":"The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae","volume":"74","author":"Wang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-1135(99)00063-2","article-title":"Newly discovered viruses of flying foxes","volume":"68","author":"Halpin","year":"1999","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1751-0813.1998.tb12335.x","article-title":"Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats","volume":"76","author":"Williamson","year":"1998","journal-title":"Aust Vet J"},{"key":"10.1016\/j.biologicals.2004.07.001_bib42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0749-0739(17)30098-6","article-title":"Hendra and Nipah virus infections","volume":"16","author":"Hooper","year":"2000","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.biologicals.2004.07.001_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0306-9877(02)00377-8","article-title":"The Australian paralysis tick may be the missing link in the transmission of Hendra virus from bats to horses to humans","volume":"60","author":"Barker","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biologicals.2004.07.001_bib44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.5694\/j.1326-5377.1995.tb126050.x","article-title":"Infection of humans and horses by a newly described morbillivirus","volume":"162","author":"Selvey","year":"1995","journal-title":"Med J Aust"},{"key":"10.1016\/j.biologicals.2004.07.001_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.20506\/rst.19.1.1203","article-title":"Hendra virus disease in horses","volume":"19","author":"Westbury","year":"2000","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.biologicals.2004.07.001_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/tvjl.2000.0508","article-title":"Hendra (equine morbillivirus)","volume":"160","author":"Barclay","year":"2000","journal-title":"Vet J"},{"key":"10.1016\/j.biologicals.2004.07.001_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0166-0934(01)00354-8","article-title":"Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus","volume":"98","author":"Smith","year":"2001","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2004.07.001_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.2042-3306.1972.tb03900.x","article-title":"Japanese encephalitis in horses in Japan","volume":"4","author":"Nakamura","year":"1972","journal-title":"Equine Vet J"},{"key":"10.1016\/j.biologicals.2004.07.001_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1751-0813.1968.tb04908.x","article-title":"Japanese B encephalitis in a horse","volume":"44","author":"Chong Sue","year":"1968","journal-title":"Aust Vet J"},{"key":"10.1016\/j.biologicals.2004.07.001_bib50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/viro.2000.0305","article-title":"Identification and phylogenetic comparison of Salem virus, a novel paramyxovirus of horses","volume":"270","author":"Renshaw","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2004.07.001_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1135(02)00067-6","article-title":"Isolation of Salem virus, a novel equine paramyxovirus, and assessment of its etiologic role in a disease outbreak","volume":"87","author":"Glaser","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0749-0739(17)30089-5","article-title":"Vesicular stomatitis and other vesicular, erosive, and ulcerative diseases of horses","volume":"16","author":"McCluskey","year":"2000","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.biologicals.2004.07.001_bib53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/CDLI.8.3.475-481.2001","article-title":"Development of an immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay for detection of equine and swine IgM antibodies to vesicular stomatitis virus","volume":"8","author":"Zhou","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-642-59403-8_14","article-title":"West Nile virus in livestock and wildlife","volume":"267","author":"McLean","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid0804.010239","article-title":"Experimental infection of horses with West Nile virus","volume":"8","author":"Bunning","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biologicals.2004.07.001_bib56","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2460\/javma.2003.222.1241","article-title":"West Nile virus encephalomyelitis in horses: 46 cases (2001)","volume":"222","author":"Porter","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.biologicals.2004.07.001_bib57","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1099\/0022-1317-82-7-1725","article-title":"Equine rhinitis A virus: structural proteins and immune response","volume":"82","author":"Hartley","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib58","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1099\/0022-1317-82-11-2641","article-title":"Equine rhinitis B virus: a new serotype","volume":"82","author":"Huang","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib59","first-page":"79","article-title":"The classification of seven serotypes of equine encephalosis virus and the prevalence of homologous antibody in horses in South Africa","volume":"69","author":"Howell","year":"2002","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.biologicals.2004.07.001_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1439-0450.2002.00510.x","article-title":"Nested reverse transcriptase-polymerase chain reaction for the detection of group A rotaviruses","volume":"49","author":"Elschner","year":"2002","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.biologicals.2004.07.001_bib61","first-page":"132","article-title":"The action of proteolytic enzymes on the antitoxins and proteins in immune sera. I. True digestion of the proteins","volume":"20","author":"Pope","year":"1939","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib62","first-page":"201","article-title":"The action of proteolytic enzymes on the antitoxins and proteins in immune sera. II. Heat denaturation after partial enzyme action","volume":"20","author":"Pope","year":"1939","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib63","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1042\/bj0420390","article-title":"The purification of antitoxic plasmas by enzyme treatment and heat denaturation","volume":"42","author":"Harms","year":"1948","journal-title":"Biochem J"},{"key":"10.1016\/j.biologicals.2004.07.001_bib64","series-title":"Handbook of natural toxins. Reptile venoms and toxins","first-page":"557","article-title":"Antivenins in Brazil: preparation","author":"Raw","year":"1991"},{"key":"10.1016\/j.biologicals.2004.07.001_bib65","series-title":"Reptile venoms and toxins","first-page":"583","article-title":"Antivenin production in India","volume":"vol. 5","author":"Jadhav","year":"1991"},{"key":"10.1016\/j.biologicals.2004.07.001_bib66","series-title":"Envenomings and their treatments","first-page":"161","article-title":"Preparation of improved F(ab\u2032)2 antivenoms. An example: new polyvalent European viper antivenom (equine)","author":"Grandgeorge","year":"1996"},{"key":"10.1016\/j.biologicals.2004.07.001_bib67","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-1759(03)00005-X","article-title":"A protocol for \u2018enhanced pepsin digestion\u2019: a step by step method for obtaining pure antibody fragments in high yield from serum","volume":"275","author":"Jones","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.biologicals.2004.07.001_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(97)00244-2","article-title":"Quantitative comparison on the refinement of horse antivenom by salt fractionation and ion-exchange chromatography","volume":"700","author":"Saetang","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.biologicals.2004.07.001_bib69","series-title":"Manual de Procedimientos. Producci\u00f3n y Pruebas de Control en la Preparaci\u00f3n de Antisueros Dift\u00e9rico, Tet\u00e1nico, Botul\u00ednico, Antivenenos y de la Gangrena Gaseosa","article-title":"Antivenenos","author":"Bola\u00f1os","year":"1977"},{"key":"10.1016\/j.biologicals.2004.07.001_bib70","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0041-0101(89)90177-3","article-title":"Purification of F(ab\u2032)2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield","volume":"27","author":"dos Santos","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0041-0101(98)00220-7","article-title":"A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms","volume":"37","author":"Otero","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0041-0101(94)90087-6","article-title":"Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production","volume":"32","author":"Rojas","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0041-0101(94)90107-4","article-title":"A new antivenom to treat eastern coral snake (Micrurus fulvius fulvius) envenoming","volume":"32","author":"Rawat","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2796.1997.80896000.x","article-title":"First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming","volume":"241","author":"Karlson-Stiber","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.biologicals.2004.07.001_bib75","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.1997.56.291","article-title":"First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom","volume":"56","author":"Meyer","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2004.07.001_bib76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S0036-46651997000200010","article-title":"Effect of beta-propiolactone treatment on the complement activation mediated by equine antisera","volume":"39","author":"Guidolin","year":"1997","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.biologicals.2004.07.001_bib77","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.biologicals.2004.07.001_bib78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0041-0101(90)90011-U","article-title":"Effect of storage temperature on the stability of the liquid polyvalent antivenom produced in Costa Rica","volume":"28","author":"Rojas","year":"1990","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib79","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/biol.2002.0329","article-title":"Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation","volume":"30","author":"Garcia","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2004.07.001_bib80","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1054\/blre.2000.0129","article-title":"Reducing the risk of infection from plasma products: specific preventative strategies","volume":"14","author":"Burnouf","year":"2000","journal-title":"Blood Rev"},{"key":"10.1016\/j.biologicals.2004.07.001_bib81","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1258\/0023677021911740","article-title":"Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units","volume":"36","author":"Nicklas","year":"2002","journal-title":"Lab Anim"},{"key":"10.1016\/j.biologicals.2004.07.001_bib82","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1258\/002367700780387723","article-title":"FELASA recommendations for the health monitoring of experimental units of calves, sheep and goats Report of the federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health","volume":"34","author":"Rehbinder","year":"2000","journal-title":"Lab Anim"},{"key":"10.1016\/j.biologicals.2004.07.001_bib83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1258\/002367796780684881","volume":"30","author":"Rehbinder","year":"1996","journal-title":"Lab Anim"},{"key":"10.1016\/j.biologicals.2004.07.001_bib84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0378-4347(94)00532-A","article-title":"Chromatography in plasma fractionation: benefits and future trends","volume":"664","author":"Burnouf","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"key":"10.1016\/j.biologicals.2004.07.001_bib85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1423-0410.1988.tb01606.x","article-title":"Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids","volume":"54","author":"Horowitz","year":"1988","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2004.07.001_bib86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1423-0410.1991.tb00878.x","article-title":"Inactivation of lipid-enveloped viruses in proteins by caprylate","volume":"60","author":"Lundblad","year":"1991","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2004.07.001_bib87","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/biol.2002.0332","article-title":"Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution","volume":"30","author":"Dichtelmuller","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2004.07.001_bib88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/biol.2002.0334","article-title":"Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates","volume":"30","author":"Korneyeva","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2004.07.001_bib89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1045-1056(03)00062-9","article-title":"Low pH, caprylate incubation as a second viral inactivation step in the manufacture of albumin. Parametric and validation studies","volume":"31","author":"Johnston","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2004.07.001_bib90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1423-0410.1988.tb05140.x","article-title":"Potential contribution of mild pepsin treatment at pH4 to the viral safety of human immunoglobulin products","volume":"55","author":"Reid","year":"1988","journal-title":"Vox Sang"},{"issue":"Suppl. 1","key":"10.1016\/j.biologicals.2004.07.001_bib91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.1996.104.s1.35","article-title":"The viral safety of intravenous immune globulin","volume":"104","author":"Yap","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib92","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/biol.1998.0148","article-title":"Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process","volume":"26","author":"Bos","year":"1998","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2004.07.001_bib93","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1537-2995.1996.361097017171.x","article-title":"Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation","volume":"36","author":"Omar","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.07.001_bib94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1423-0410.1992.tb01211.x","article-title":"Virus inactivation during intravenous immunoglobulin production","volume":"63","author":"Hamalainen","year":"1992","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2004.07.001_bib95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1246-7820(05)80044-8","article-title":"Viral safety of intravenous immunoglobulins G for therapeutic use","volume":"2","author":"Burnouf-Radosevich","year":"1995","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib96","first-page":"23","article-title":"Strategies to produce virus-safe blood derivatives","author":"Heimburger","year":"1989","journal-title":"Curr Stud Hematol Blood Transfus"},{"key":"10.1016\/j.biologicals.2004.07.001_bib97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1537-2995.1985.25686071423.x","article-title":"Inactivation of viruses in labile blood derivatives. II. Physical methods","volume":"25","author":"Horowitz","year":"1985","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.07.001_bib98","first-page":"621","article-title":"Pasteurization as an efficient method to inactivate blood borne viruses in factor VIII concentrates","volume":"36","author":"Hilfenhaus","year":"1986","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biologicals.2004.07.001_bib99","first-page":"169","article-title":"Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation","volume":"81","author":"Nowak","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2004.07.001_bib100","first-page":"91","article-title":"A pasteurized therapeutic plasma","volume":"19","author":"Burnouf-Radosevich","year":"1992","journal-title":"Infusionsther Transfusionsmed"},{"key":"10.1016\/j.biologicals.2004.07.001_bib101","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0049-3848(85)90167-7","article-title":"Pasteurization of antihemophilic factor and model virus inactivation studies","volume":"39","author":"Ng","year":"1985","journal-title":"Thromb Res"},{"key":"10.1016\/j.biologicals.2004.07.001_bib102","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1365-2516.2000.00435.x","article-title":"Virucidal heat-treatment of single plasma units: a potential approach for developing countries","volume":"6","author":"Goubran","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2004.07.001_bib103","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1537-2995.2003.00496.x","article-title":"West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data","volume":"43","author":"Kreil","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2004.07.001_bib104","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0165-022X(01)00221-4","article-title":"Affinity chromatography in the industrial purification of plasma proteins for therapeutic use","volume":"49","author":"Burnouf","year":"2001","journal-title":"J Biochem Biophys Methods"},{"key":"10.1016\/j.biologicals.2004.07.001_bib105","first-page":"199","article-title":"Chromatographic removal of viruses from plasma derivatives","volume":"81","author":"Burnouf","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2004.07.001_bib106","first-page":"193","article-title":"A comparative in vitro study of low pH and enzyme treated immunoglobulin preparation for intravenous use","volume":"29","author":"Nisini","year":"1989","journal-title":"J Clin Lab Immunol"},{"key":"10.1016\/j.biologicals.2004.07.001_bib107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/biol.1994.1003","article-title":"Inactivation of hepatitis C virus in low pH intravenous immunoglobulin","volume":"22","author":"Louie","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2004.07.001_bib108","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0041-0101(03)00170-3","article-title":"Formulation of a liquid ovine Fab-based antivenom for the treatment of envenomation by the Nigerian carpet viper (Echis ocellatus)","volume":"42","author":"Al-Abdulla","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2004.07.001_bib110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2516.2003.00701.x","article-title":"Nanofiltration of plasma-derived biopharmaceutical products","volume":"9","author":"Burnouf","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2004.07.001_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/biol.2002.0335","article-title":"Inactivation of West-Nile virus during peptic cleavage of horse plasma IgG","volume":"30","author":"Lazar","year":"2002","journal-title":"Biologicals"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105604000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105604000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T04:33:22Z","timestamp":1585888402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105604000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1045105604000223"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2004.07.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}